Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients [NA]

View source ↗

Summary

This document reports the completion of a clinical trial comparing vildagliptin to glimepiride in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)
  • Vildagliptin (vildagliptin)

Snippet

Sponsor: Damanhour University | Conditions: Type 2 Diabetes | NA | Status: COMPLETED